- Confirmed: 这个参考离子已经通过手动审计得到确认和验证。
- Reliable: 这个参考离子可能在特定的解剖组织环境中高度保守。
- Unreliable: 这个参考离子具有较高的排名价值,但缺乏可重复性。
- Unavailable: 由于排名价值低且缺乏可重复性,这个参考离子不应用于注释。
Found 19 Reference Ions Near m/z 808.5569
NovoCell ID | m/z | Mass Window | Metabolite | Ranking | Anatomy Context |
---|---|---|---|---|---|
MSI_000043807 Reliable | 808.5517 | 808.5511 ~ 808.5519 MzDiff: 3.4 ppm |
3-O-Sulfogalactosylceramide (d18:1/18:0) (BioDeep_00000032549) Formula: C42H81NO11S (807.553) |
4.7 (100%) | Homo sapiens [UBERON:0001043] esophagus |
MSI_000020385 Reliable | 808.5516 | 808.5511 ~ 808.5519 MzDiff: 3.4 ppm |
Solanesyl-PP (BioDeep_00000005423) Formula: C45H76O7P2 (790.5066) |
8.43 (73%) | Rattus norvegicus [UBERON:0004359] corpus epididymis |
MSI_000020457 Reliable | 808.5644 | 808.5641 ~ 808.5648 MzDiff: 3.0 ppm |
PE(18:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) (BioDeep_00000186162) Formula: C45H78NO9P (807.5414) |
5.74 (100%) | Rattus norvegicus [UBERON:0004359] corpus epididymis |
MSI_000046691 Reliable | 808.5482 | 808.5482 ~ 808.5482 MzDiff: none |
PI(16:0/16:1) (BioDeep_00000019300) Formula: C41H77O13P (808.5102) |
3.68 (100%) | Mus musculus [UBERON:0002107] liver |
MSI_000006968 | 808.5584 | 808.5582 ~ 808.5588 MzDiff: 2.5 ppm |
PE(18:0/20:3(6,8,11)-OH(5)) (BioDeep_00000186184) Formula: C43H80NO9P (785.557) |
2.17 (100%) | Rattus norvegicus [UBERON:0004358] caput epididymis |
MSI_000021097 Unreliable | 808.5578 | 808.5575 ~ 808.558 MzDiff: 2.1 ppm |
PE(18:0/20:3(6,8,11)-OH(5)) (BioDeep_00000186184) Formula: C43H80NO9P (785.557) |
5.02 (80%) | Rattus norvegicus [UBERON:0004359] corpus epididymis |
MSI_000011684 Unavailable | 808.5549 | 808.5549 ~ 808.5549 MzDiff: none |
3-O-Sulfogalactosylceramide (d18:1/18:0) (BioDeep_00000032549) Formula: C42H81NO11S (807.553) |
-2.03 (100%) | Mus musculus [UBERON:0012378] muscle layer of urinary bladder |
MSI_000006812 | 808.5639 | 808.5639 ~ 808.5639 MzDiff: none |
PE(18:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) (BioDeep_00000186162) Formula: C45H78NO9P (807.5414) |
2.59 (100%) | Rattus norvegicus [UBERON:0004358] caput epididymis |
MSI_000008871 Unreliable | 808.5635 | 808.5635 ~ 808.5635 MzDiff: none |
Not Annotated | 3.23 (0%) | Mus musculus [UBERON:0004645] urinary bladder urothelium |
MSI_000009151 Unreliable | 808.5549 | 808.5549 ~ 808.5549 MzDiff: none |
3-O-Sulfogalactosylceramide (d18:1/18:0) (BioDeep_00000032549) Formula: C42H81NO11S (807.553) |
3.03 (100%) | Mus musculus [UBERON:0004645] urinary bladder urothelium |
MSI_000057576 Unreliable | 808.5502 | 808.5501 ~ 808.5503 MzDiff: 1.1 ppm |
PE(18:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) (BioDeep_00000186162) Formula: C45H78NO9P (807.5414) |
0.91 (100%) | Homo sapiens [UBERON:0007779] transudate |
MSI_000000709 Unavailable | 808.5635 | 808.5635 ~ 808.5635 MzDiff: none |
Not Annotated | -0.56 (0%) | Mus musculus [CL:0000066] epithelial cell |
MSI_000000756 Unavailable | 808.5549 | 808.5549 ~ 808.5549 MzDiff: none |
3-O-Sulfogalactosylceramide (d18:1/18:0) (BioDeep_00000032549) Formula: C42H81NO11S (807.553) |
-0.58 (100%) | Mus musculus [CL:0000066] epithelial cell |
MSI_000028690 Unreliable | 808.5634 | 808.5634 ~ 808.5634 MzDiff: none |
PE(18:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) (BioDeep_00000186162) Formula: C45H78NO9P (807.5414) |
0.58 (100%) | Macropus giganteus [UBERON:0001891] midbrain |
MSI_000029180 Unreliable | 808.5542 | 808.5542 ~ 808.5542 MzDiff: none |
PE(18:0/20:3(6,8,11)-OH(5)) (BioDeep_00000186184) Formula: C43H80NO9P (785.557) |
1.71 (100%) | Macropus giganteus [UBERON:0002336] corpus callosum |
MSI_000029182 Unreliable | 808.5634 | 808.5634 ~ 808.5634 MzDiff: none |
PE(18:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) (BioDeep_00000186162) Formula: C45H78NO9P (807.5414) |
1.71 (100%) | Macropus giganteus [UBERON:0002336] corpus callosum |
MSI_000044836 Unavailable | 808.5617 | 808.5617 ~ 808.5617 MzDiff: none |
Oligomycin (BioDeep_00000181948) Formula: C45H74O11 (790.5231) |
-0.49 (100%) | Rattus norvegicus [UBERON:0002264] olfactory bulb |
MSI_000056209 Unavailable | 808.5528 | 808.5528 ~ 808.5528 MzDiff: none |
3-O-Sulfogalactosylceramide (d18:1/18:0) (BioDeep_00000032549) Formula: C42H81NO11S (807.553) |
-0.57 (100%) | Homo sapiens [UBERON:0007779] transudate |
MSI_000057413 Unreliable | 808.5481 | 808.5481 ~ 808.5481 MzDiff: none |
PI(16:0/16:1) (BioDeep_00000019300) Formula: C41H77O13P (808.5102) |
1.03 (100%) | Homo sapiens [UBERON:0007779] transudate |
Found 23 Sample Hits
Metabolite | Species | Sample | |
---|---|---|---|
3-O-Sulfogalactosylceramide (d18:1/18:0) Formula: C42H81NO11S (807.553) Adducts: [M+H]+ (Ppm: 6.7) |
Mus musculus (Urinary bladder) |
HR2MSI_mouse_urinary_bladder - S096Resolution: 10μm, 260x134
Mass spectrometry imaging of phospholipids in mouse urinary bladder (imzML dataset) |
|
PE(18:0/20:3(6,8,11)-OH(5)) Formula: C43H80NO9P (785.557) Adducts: [M+Na]+ (Ppm: 15.5) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito03_17Resolution: 17μm, 208x108
1 male adult wild-type rat was obtained from Inserm U1085 - Irset Research Institute (University of Rennes1, France). Animals were age 60 days and were reared under ad-lib conditions. Care and handling of all animals complied with EU directive 2010/63/EU on the protection of animals used for scientific purposes. The whole epididymis was excised from each animal immediately post-mortem, loosely wrapped rapidly in an aluminum foil and a 2.5% (w/v) carboxymethylcellulose (CMC) solution was poured to embed the epididymis to preserve their morphology. To remove air bubbles, the filled aluminum molds was gently freezed by depositing it on isopentane or dry ice, then on the nitrogen vapors and finally by progressively dipping the CMC/sample coated with aluminum foil into liquid nitrogen (or only flush with liquid nitrogen). Frozen tissues were stored at -80 °C until use to avoid degradation. |
|
PE(18:0/20:3(6,8,11)-OH(5)) Formula: C43H80NO9P (785.557) Adducts: [M+Na]+ (Ppm: 14.4) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito03_18Resolution: 17μm, 208x104
|
|
PE(18:0/20:3(6,8,11)-OH(5)) Formula: C43H80NO9P (785.557) Adducts: [M+Na]+ (Ppm: 14.8) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito08_44Resolution: 17μm, 299x111
|
|
PE(18:0/20:3(6,8,11)-OH(5)) Formula: C43H80NO9P (785.557) Adducts: [M+Na]+ (Ppm: 13.2) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito08_46Resolution: 17μm, 298x106
|
|
PE(18:0/20:3(6,8,11)-OH(5)) Formula: C43H80NO9P (785.557) Adducts: [M+Na]+ (Ppm: 14.1) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito01_04Resolution: 17μm, 178x91
|
|
PE(18:0/20:3(6,8,11)-OH(5)) Formula: C43H80NO9P (785.557) Adducts: [M+Na]+ (Ppm: 13.9) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito01_03Resolution: 17μm, 159x110
|
|
PE(18:0/20:3(6,8,11)-OH(5)) Formula: C43H80NO9P (785.557) Adducts: [M+Na]+ (Ppm: 14.1) |
Rattus norvegicus (normal) |
epik_dhb_head_ito01_05Resolution: 17μm, 183x105
|
|
PE(18:0/20:3(6,8,11)-OH(5)) Formula: C43H80NO9P (785.557) Adducts: [M+Na]+ (Ppm: 14.1) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito01_06Resolution: 17μm, 183x103
|
|
PE(18:0/20:3(6,8,11)-OH(5)) Formula: C43H80NO9P (785.557) Adducts: [M+Na]+ (Ppm: 15.1) |
Rattus norvegicus (Epididymis) |
epik_dhb_head_ito03_14Resolution: 17μm, 205x103
|
|
PE(18:0/20:3(6,8,11)-OH(5)) Formula: C43H80NO9P (785.557) Adducts: [M+Na]+ (Ppm: 9.8) |
Macropus giganteus (Brain) |
170321_kangaroobrain-dan3-pos_maxof50.0_med1Resolution: 50μm, 81x50
Sample information
Organism: Macropus giganteus (kangaroo)
Organism part: Brain
Condition: Wildtype
Sample growth conditions: Wild |
|
3-O-Sulfogalactosylceramide (d18:1/18:0) Formula: C42H81NO11S (807.553) Adducts: [M+H]+ (Ppm: 8.8) |
Homo sapiens (esophagus) |
LNTO22_1_9Resolution: 75μm, 89x74
|
|
PI(16:0/16:1) Formula: C41H77O13P (808.5102) Adducts: [M-H2O+NH4]+ (Ppm: 18.3) |
Mus musculus (Liver) |
Salmonella_final_pos_recalResolution: 17μm, 691x430
A more complete and holistic view on host–microbe interactions is needed to understand the physiological and cellular barriers that affect the efficacy of drug treatments and allow the discovery and development of new therapeutics. Here, we developed a multimodal imaging approach combining histopathology with mass spectrometry imaging (MSI) and same section imaging mass cytometry (IMC) to study the effects of Salmonella Typhimurium infection in the liver of a mouse model using the S. Typhimurium strains SL3261 and SL1344. This approach enables correlation of tissue morphology and specific cell phenotypes with molecular images of tissue metabolism. IMC revealed a marked increase in immune cell markers and localization in immune aggregates in infected tissues. A correlative computational method (network analysis) was deployed to find metabolic features associated with infection and revealed metabolic clusters of acetyl carnitines, as well as phosphatidylcholine and phosphatidylethanolamine plasmalogen species, which could be associated with pro-inflammatory immune cell types. By developing an IMC marker for the detection of Salmonella LPS, we were further able to identify and characterize those cell types which contained S. Typhimurium.
[dataset] Nicole Strittmatter. Holistic Characterization of a Salmonella Typhimurium Infection Model Using Integrated Molecular Imaging, metabolights_dataset, V1; 2022. https://www.ebi.ac.uk/metabolights/MTBLS2671. |
|
PE(18:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) Formula: C45H78NO9P (807.5414) Adducts: [M+H]+ (Ppm: 1.8) |
Homo sapiens (esophagus) |
LNTO29_16_3Resolution: 17μm, 108x107
|
|
3-O-Sulfogalactosylceramide (d18:1/18:0) Formula: C42H81NO11S (807.553) Adducts: [M+H]+ (Ppm: 10.1) |
Homo sapiens (esophagus) |
LNTO26_7_1Resolution: 17μm, 75x74
|
|
3-O-Sulfogalactosylceramide (d18:1/18:0) Formula: C42H81NO11S (807.553) Adducts: [M+H]+ (Ppm: 9.3) |
Homo sapiens (esophagus) |
LNTO26_7_2Resolution: 17μm, 135x101
|
|
3-O-Sulfogalactosylceramide (d18:1/18:0) Formula: C42H81NO11S (807.553) Adducts: [M+H]+ (Ppm: 9.4) |
Homo sapiens (esophagus) |
LNTO22_1_5Resolution: 75μm, 135x94
|
|
3-O-Sulfogalactosylceramide (d18:1/18:0) Formula: C42H81NO11S (807.553) Adducts: [M+H]+ (Ppm: 9.9) |
Homo sapiens (esophagus) |
LNTO22_1_7Resolution: 75μm, 69x54
|
|
3-O-Sulfogalactosylceramide (d18:1/18:0) Formula: C42H81NO11S (807.553) Adducts: [M+H]+ (Ppm: 10.6) |
Homo sapiens (esophagus) |
LNTO22_2_1Resolution: 75μm, 89x88
|
|
3-O-Sulfogalactosylceramide (d18:1/18:0) Formula: C42H81NO11S (807.553) Adducts: [M+H]+ (Ppm: 9.7) |
Homo sapiens (esophagus) |
LNTO22_2_2Resolution: 75μm, 135x94
|
|
3-O-Sulfogalactosylceramide (d18:1/18:0) Formula: C42H81NO11S (807.553) Adducts: [M+H]+ (Ppm: 10.4) |
Homo sapiens (esophagus) |
LNTO26_16_1Resolution: 75μm, 95x88
|
|
PE(18:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) Formula: C45H78NO9P (807.5414) Adducts: [M+H]+ (Ppm: 2) |
Homo sapiens (esophagus) |
LNTO29_18_2Resolution: 75μm, 62x68
|
|
3-O-Sulfogalactosylceramide (d18:1/18:0) Formula: C42H81NO11S (807.553) Adducts: [M+H]+ (Ppm: 0.6) |
Homo sapiens (colorectal adenocarcinoma) |
240TopL, 210TopR, 230BottomL, 220BottomR-centroidResolution: 50μm, 142x141
|
|